Interstitial Lung Disease Autoantibody Panel
Ordering Recommendation
May be useful for evaluation of interstitial lung disease in the context of systemic autoimmune rheumatic disease (ie, connective tissue disease).
New York DOH Approval Status
Specimen Required
Serum Separator Tube (SST).
Separate from cells ASAP or within 2 hours of collection. Transfer five 1 mL serum aliquots to ARUP Standard Transport Tubes. (Min: 2.8 mL)
Refrigerated.
Hemolyzed, hyperlipemic, icteric, heat-treated or contaminated specimens.
Ambient: 24 hours; Refrigerated: 1 weeks; Frozen: 1 month
Methodology
Qualitative Immunoprecipitation/Semi-Quantitative Multiplex Bead Assay/Qualitative Immunoblot/Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Quantitative Immunoturbidimetry
Performed
Sun-Sat
Reported
7-18 days
Reference Interval
Test Number |
Components |
Reference Interval |
---|---|---|
Rheumatoid Factor | 0-14 IU/mL | |
Antinuclear Antibody (ANA), HEp-2, IgG | Less than 1:80 | |
Scleroderma (Scl-70) (ENA) Antibody, IgG | 40 AU/mL or less | |
SSA-52 (Ro52) (ENA) Antibody, IgG | 40 AU/mL or less | |
Jo-1 (Histidyl-tRNA Synthetase) Ab, IgG | 40 AU/mL or less | |
PL-7 (threonyl-tRNA synthetase) Antibody | Negative | |
PL-12 (alanyl-tRNA synthetase) Antibody | Negative | |
EJ (glycyl-tRNA synthetase) Antibody | Negative | |
Ku Antibody | Negative | |
SRP (Signal Recognition Particle) Ab | Negative | |
OJ (isoleucyl-tRNA synthetase) Antibody | Negative | |
SSA-60 (Ro60) (ENA) Antibody, IgG | 40 AU/mL or less | |
MDA5 (CADM-140) Ab | Negative | |
NXP2 (Nuclear matrix protein-2) Ab | Negative | |
PM/Scl 100 Antibody, IgG | Negative | |
RNA Polymerase III Antibody, IgG | 19 Units or less | |
Cyclic Citrullinated Peptide Ab, IgG/A | 19 Units or less |
Interpretive Data
Refer to report.
Component |
Interpretation |
|
---|---|---|
SSA-52 (Ro52) (ENA) Antibody, IgG | 29 AU/mL or Less 30-40 AU/mL 41 AU/mL or greater |
Negative Equivocal Positive |
SSA-60 (Ro60) (ENA) Antibody, IgG | 29 AU/mL or Less 30-40 AU/mL 41 AU/mL or greater |
Negative Equivocal Positive |
Scleroderma (Scl-70) (ENA) Antibody, IgG | 29 AU/mL or less 30-40 AU/mL 41 AU/mL or greater |
Negative Equivocal Positive |
Jo-1 Antibody, IgG | 29 AU/mL or less 30-40 AU/mL 41 AU/mL or greater |
Negative Equivocal Positive |
Cyclic Citrullinated Peptide (CCP) Ab, IgG/A | 19 Units or less 20-39 Units 40-59 Units 60 Units or Greater |
Negative Weak positive Moderate positive Strong positive |
RNA Polymerase III Antibody, IgG | 19 Units or less 20-39 Units 40-80 Units 81 Units or greater |
Negative Weak positive Moderate positive Strong positive |
Laboratory Developed Test (LDT)
Note
Antibodies: Ro52, Ro60, Jo-1, PL-7, PL12, EJ, Ku, SRP, OJ, PM/Scl-100, MDA5, CCP, Scl-70, RA, ANA, NXP-2, RNA Polymerase III
Hotline History
Hotline History
CPT Codes
86235 x5; 83516 x7; 84182 x2; 86431; 86200; 86039
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0050465 | Rheumatoid Factor | 11572-5 |
0050599 | Scleroderma (Scl-70) (ENA) Antibody, IgG | 47322-3 |
0050691 | SSA-52 (Ro52) (ENA) Antibody, IgG | 31625-7 |
0099592 | Jo-1 (Histidyl-tRNA Synthetase) Ab, IgG | 33571-1 |
2001602 | RNA Polymerase III Antibody, IgG | 79182-2 |
2003041 | PM/Scl 100 Antibody, IgG | 81732-0 |
2010853 | PL-7 (threonyl-tRNA synthetase) Antibody | 33772-5 |
2010854 | PL-12 (alanyl-tRNA synthetase) Antibody | 33771-7 |
2010856 | EJ (glycyl-tRNA synthetase) Antibody | 45149-2 |
2010857 | Ku Antibody | 18484-6 |
2010859 | SRP (Signal Recognition Particle) Ab | 33921-8 |
2010860 | OJ (isoleucyl-tRNA synthetase) Antibody | 45152-6 |
2012055 | SSA-60 (Ro60) (ENA) Antibody, IgG | 53019-6 |
2013998 | Interpretive Information | 48767-8 |
3000090 | Antinuclear Antibody (ANA), HEp-2, IgG | 21424-7 |
3000096 | ANA Interpretive Comment | 49311-4 |
3001787 | MDA5 (CADM-140) Ab | 82424-3 |
3001788 | NXP2 (Nuclear matrix protein-2) Ab | 82426-8 |
3016633 | Cyclic Citrullinated Peptide Ab, IgG/A | 57093-7 |